久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/10 | 6,150 | 6,190 | 6,130 | 6,170 | -10 | -0.2% | 81,500 |
2020/12/09 | 6,090 | 6,180 | 6,080 | 6,180 | +110 | +1.8% | 83,000 |
2020/12/08 | 6,080 | 6,090 | 6,020 | 6,070 | -60 | -1% | 75,300 |
2020/12/07 | 6,270 | 6,270 | 6,110 | 6,130 | -80 | -1.3% | 98,600 |
2020/12/04 | 6,100 | 6,240 | 6,090 | 6,210 | +120 | +2% | 108,700 |
2020/12/03 | 6,280 | 6,300 | 6,040 | 6,090 | -140 | -2.2% | 160,800 |
2020/12/02 | 6,280 | 6,280 | 6,160 | 6,230 | +20 | +0.3% | 142,200 |
2020/12/01 | 6,180 | 6,240 | 6,130 | 6,210 | +90 | +1.5% | 138,800 |
2020/11/30 | 6,180 | 6,220 | 6,060 | 6,120 | -100 | -1.6% | 265,800 |
2020/11/27 | 6,120 | 6,270 | 6,120 | 6,220 | +140 | +2.3% | 150,300 |
2020/11/26 | 5,950 | 6,100 | 5,910 | 6,080 | +140 | +2.4% | 94,900 |
2020/11/25 | 6,000 | 6,020 | 5,930 | 5,940 | ±0 | ±0% | 126,000 |
2020/11/24 | 5,960 | 6,080 | 5,940 | 5,940 | +40 | +0.7% | 137,600 |
2020/11/20 | 5,880 | 5,910 | 5,860 | 5,900 | -10 | -0.2% | 58,500 |
2020/11/19 | 5,910 | 5,940 | 5,830 | 5,910 | -10 | -0.2% | 125,800 |
2020/11/18 | 5,960 | 5,980 | 5,870 | 5,920 | -90 | -1.5% | 101,300 |
2020/11/17 | 5,860 | 6,010 | 5,800 | 6,010 | +170 | +2.9% | 161,700 |
2020/11/16 | 5,760 | 5,890 | 5,720 | 5,840 | +210 | +3.7% | 103,800 |
2020/11/13 | 5,710 | 5,730 | 5,590 | 5,630 | -140 | -2.4% | 91,200 |
2020/11/12 | 5,700 | 5,780 | 5,690 | 5,770 | +20 | +0.3% | 72,200 |
2020/11/11 | 5,770 | 5,790 | 5,630 | 5,750 | +130 | +2.3% | 144,700 |
2020/11/10 | 5,600 | 5,700 | 5,590 | 5,620 | +150 | +2.7% | 138,800 |
2020/11/09 | 5,490 | 5,500 | 5,380 | 5,470 | +60 | +1.1% | 84,900 |
2020/11/06 | 5,390 | 5,440 | 5,360 | 5,410 | -10 | -0.2% | 90,600 |
2020/11/05 | 5,330 | 5,450 | 5,270 | 5,420 | +120 | +2.3% | 126,700 |
2020/11/04 | 5,200 | 5,340 | 5,150 | 5,300 | +160 | +3.1% | 118,000 |
2020/11/02 | 5,040 | 5,190 | 5,030 | 5,140 | +165 | +3.3% | 116,900 |
2020/10/30 | 5,050 | 5,050 | 4,955 | 4,975 | -115 | -2.3% | 133,900 |
2020/10/29 | 5,090 | 5,130 | 5,060 | 5,090 | +20 | +0.4% | 62,700 |
2020/10/28 | 4,980 | 5,080 | 4,940 | 5,070 | +40 | +0.8% | 86,700 |
2020/10/27 | 5,030 | 5,030 | 4,955 | 5,030 | -50 | -1% | 62,100 |
2020/10/26 | 5,090 | 5,140 | 5,030 | 5,080 | -50 | -1% | 58,000 |
2020/10/23 | 5,080 | 5,180 | 5,060 | 5,130 | +30 | +0.6% | 71,100 |
2020/10/22 | 5,150 | 5,160 | 5,050 | 5,100 | -120 | -2.3% | 75,000 |
2020/10/21 | 5,160 | 5,250 | 5,140 | 5,220 | +90 | +1.8% | 65,500 |
2020/10/20 | 5,190 | 5,230 | 5,100 | 5,130 | -90 | -1.7% | 81,300 |
2020/10/19 | 5,090 | 5,250 | 5,090 | 5,220 | +150 | +3% | 60,700 |
2020/10/16 | 5,100 | 5,110 | 5,040 | 5,070 | -50 | -1% | 71,600 |
2020/10/15 | 5,190 | 5,250 | 5,110 | 5,120 | -120 | -2.3% | 95,100 |
2020/10/14 | 5,280 | 5,320 | 5,190 | 5,240 | -70 | -1.3% | 95,400 |
2020/10/13 | 5,290 | 5,320 | 5,230 | 5,310 | +40 | +0.8% | 54,500 |
2020/10/12 | 5,350 | 5,420 | 5,230 | 5,270 | -60 | -1.1% | 97,700 |
2020/10/09 | 5,550 | 5,630 | 5,240 | 5,330 | -30 | -0.6% | 159,300 |
2020/10/08 | 5,360 | 5,420 | 5,330 | 5,360 | +60 | +1.1% | 99,200 |
2020/10/07 | 5,330 | 5,350 | 5,190 | 5,300 | -90 | -1.7% | 133,000 |
2020/10/06 | 5,340 | 5,390 | 5,300 | 5,390 | +70 | +1.3% | 104,800 |
2020/10/05 | 5,250 | 5,410 | 5,250 | 5,320 | +130 | +2.5% | 90,000 |
2020/10/02 | 5,330 | 5,350 | 5,130 | 5,190 | - | - | 139,600 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 5,570 | 5,580 | 5,370 | 5,370 | -190 | -3.4% | 124,700 |
1151~
1200
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 322,600円 | +3.6% | -15.3% | 3.84% | 9.06倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム